# Improved Recovery by Iron Following Surgery With Blood Loss, the IRIS-trial

Study · id `cardio:ct-nct05744219` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05744219](<https://clinicaltrials.gov/study/NCT05744219>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT05744219

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 338 participants.

## Technical summary

Registry record NCT05744219. Randomized; quadruple masking; primary purpose treatment. Start 2024-09-04 (actual); primary completion 2027-12-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 338 participants (planned count; ClinicalTrials.gov record NCT05744219, source copy `cardio:ctgov-nct05744219-2024-10-21`, retrieved 2026-11-18)
- Started: 2024-09-04 (actual) (ClinicalTrials.gov record NCT05744219, source copy `cardio:ctgov-nct05744219-2024-10-21`, retrieved 2026-11-18)
- Primary completion: 2027-12-31 (anticipated) (ClinicalTrials.gov record NCT05744219, source copy `cardio:ctgov-nct05744219-2024-10-21`, retrieved 2026-11-18)
- Completion: 2028-03-30 (anticipated) (ClinicalTrials.gov record NCT05744219, source copy `cardio:ctgov-nct05744219-2024-10-21`, retrieved 2026-11-18)
- Countries: Sweden (ClinicalTrials.gov record NCT05744219, source copy `cardio:ctgov-nct05744219-2024-10-21`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05744219-2024-10-21`, retrieved 2026-11-18)

## The registry's words

- Brief title: Improved Recovery by Iron Following Surgery With Blood Loss, the IRIS-trial
- Acronym: IRIS
- Condition: Surgery
- Condition: Liver Metastases
- Condition: Liver Cancer
- Condition: Pancreas Cancer
- Condition: Aortic Aneurysm
- Intervention (Drug): Ferric carboxymaltose
- Intervention (Drug): Placebo
- Lead sponsor: Jon Unosson
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Aortic aneurysm (`cardio:aortic-aneurysm`)
- Registry intervention name matches this record: Ferric carboxymaltose (`core:ferric-carboxymaltose`)

## Provenance

Content hash: 891d761656caec89cccaaa72690b021a34bec393e9c02c6df513f769b80c51f3
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
